Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Affymetrix climbed 30 percent in June after the firm announced early in the month that Frank Witney had rejoined the company, replacing Kevin King as president and CEO.

Affymetrix, which is currently trading at a 52-week high, led all shares in the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.